Source: International Congress 2014 – Intervening in allergic asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Saralaya, A. Menzies-Gow, I. Clifton, A. H. Mansur, A. Hart-Thomas, R. Niven (Bradford, London, Leeds, Birmingham, Huddersfield, Manchester, United Kingdom). Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study. Eur Respir J 2014; 44: Suppl. 58, 3480

Member's Comments

No comment yet.

Related content which might interest you: Omalizumab reduces exacerbations and healthcare utilisation in severe allergic asthma patients UK clinical practice - APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Interim analysis of a prospective study investigating oral corticosteroid (OCS) use in omalizumab treated severe allergic asthma patients: APEX II study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 First clinical trial of a new IgE-adsorber in allergic asthma Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma Year: 2015 Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014 Five-year clinical study of children with atopic asthma Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014 Association between control of rhinitis and control of asthma as assessed by validated questionnaires Source: International Congress 2014 – Clinical allergy Year: 2014 Serious asthma exacerbations in a hospital setting Source: International Congress 2014 – Asthma: clinical problems Year: 2014 The impact of sublingual allergen-specific therapy on asthma control and quality of life Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Clinical phenotypes in asthmatic population with severe asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 The impact of psychological distress on allergic rhinitis and asthma control Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Patterns of clinical use of omalizumab in Spain: A 5-year "real-life" study Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Subcutaneous allergen specific immunotherapy and immunological response in patients with bronchial asthma and allergic rhinitis in India Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Outcomes of immunotherapy of patients with COPD Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Study of psychiatric comorbidities in patients with bronchial asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Efficacy of omalizumab in Polish real-world patients Source: International Congress 2016 – Asthma management Year: 2016 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Influence of maternal bronchial asthma clinical phenotype on development of allergies in children Source: International Congress 2014 – Paediatric asthma: epidemiology and risk factors Year: 2014